Upgrade to SI Premium - Free Trial

OncoCyte (OCX)

3.20 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (5/16/25 *Est.)

Latest Headlines

InterVenn Biosciences adds Ford and Levine to board May 18, 2026 9:02 AM - StreetInsider InterVenn Appoints Industry Leaders Alec Ford and Mitch Levine to Board of Directors May 18, 2026 9:02 AM - PR NewsWire Full Article List